Consumers are Looking to Boiron Arnicare(R) as a Safer Option as FDA Enforces Stricter Labeling for Many Pain Relievers
Consumers, concerned with NSAIDs and their potential side effects, are turning to Boiron Arnicare as a safer choice for pain relief. Boiron, the leading manufacturer of homeopathic medicines, offers Arnicare as an affordable option for relief of muscle aches and stiffness, due to minor injuries, overexertion, and falls and reduces pain, swelling and discoloration from bruises without side effects or drug interactions. The Arnicare line of pain relievers includes oral pellets and ointment, gel and cream odorless topical formulas, as well as quick-dissolving tablets for arthritis pain.
The main active ingredient in Arnicare is homeopathic Arnica montana, a mountain daisy which is a perennial plant commonly found in the Northwestern parts of the U.S. and
“In light of the FDA ruling on NSAIDs, consumers are wondering if there is a safer, more natural medicine that can ease their pain,” Dr. Merville said. “They are finding that Boiron Arnicare is one of the best choices of treatment for both themselves and their families. Arnicare aids in a quick recovery from muscle aches, pain, swelling, as well as bruising, no matter what the activity. Taken at the onset, just when a flare of arthritic pain occurs, or after a trauma or overexertion, or even when the discomfort is caused by a change of weather, Arnicare helps decrease the pain and very often delays or avoids the need for pain killers.”
He adds that as with all pain relief medicines, consumers have to review the drug facts carefully on the packaging. He further recommends being cautious not to take pain medicine too frequently or apply it too extensively on areas of the body.
“If you seek relief of general aches or pains throughout your body then I would recommend taking Arnica in pellet form for a systemic effect,” he says, adding that for more localized pain applying a thin layer of Boiron Arnicare Gel or Cream on the affected area three times a day is sufficient to provide “adequate relief.”
Regulated by the FDA as a drug (1), Arnicare is manufactured according to the Homeopathic Pharmacopoeia of
(1) U.S. Food and Drug Administration. Sec 400.400 Conditions Under Which Homeopathic Drugs May be Marketed (CPG7132.15). Available at: www.fda.gov/ora/compliance_ref/cpg/cpgdrg/cpg400-400.html.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.